Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype characterized by the absence of the expression of receptors for estrogen (ER), progesterone (PR), and of human epidermal growth factor receptor-2 (HER2) [6]. The gene discussed is ERBB2; the disease is breast carcinoma.